Where is the live CopyMark page for USPTO serial 75545841?

The live record is at https://getcopymark.com/trademark/75545841. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns MOLECULAR ANGIOPLASTY?

According to the public USPTO record for serial number 75545841, the listed owner(s) include: Esperion Therapeutics, Inc., Esperion Therapeutics, Inc..

What is USPTO serial number 75545841?

Serial number 75545841 is the USPTO application identifier for the mark MOLECULAR ANGIOPLASTY. It is used to track examination, publication, and registration of this trademark.

What is the current status of MOLECULAR ANGIOPLASTY?

MOLECULAR ANGIOPLASTY (75545841) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover MOLECULAR ANGIOPLASTY?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: MOLECULAR ANGIOPLASTY Serial# 75545841 | status 601; last event ABN1 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MOLECULAR ANGIOPLASTY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Esperion Therapeutics, Inc.
Ann Arbor, MI
Other trademarks owned by Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.
Ann Arbor, MI
Other trademarks owned by Esperion Therapeutics, Inc.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

SCOTT E TAYLOR

SCOTT E TAYLOR ARNALL GOLDEN & GREGORY LLP2800 1 ATLANTIC CTR1201 W PEACHTREE STATLANTA, GA 30309-3450

Goods and services

Class	Description	Status	First use
005	Pharmaceutical products, namely intravenously administered recombinant- protein, alone or in association with unilamellar vessicles to promote lipid transport in the treatment of atherosclerosis and its associated complications	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Feb 27, 2002	ABN1	ABANDONMENT - EXPRESS MAILED	—
Sep 6, 2001	EX4G	SOU EXTENSION 4 GRANTED	—
Aug 23, 2001	EXT4	SOU EXTENSION 4 FILED	—
Apr 28, 2001	EX3G	SOU EXTENSION 3 GRANTED	—
Apr 12, 2001	EXT3	SOU EXTENSION 3 FILED	—
Feb 2, 2001	ABN6	ABANDONMENT - NO USE STATEMENT FILED	The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 27, 2000	EX2G	SOU EXTENSION 2 GRANTED	—
Dec 27, 2000	PETG	PETITION TO REVIVE-GRANTED	—
Sep 29, 2000	EXT2	SOU EXTENSION 2 FILED	—
Aug 5, 2000	EX1G	SOU EXTENSION 1 GRANTED	—
May 11, 2000	PETR	PETITION TO REVIVE-RECEIVED	—
Apr 12, 2000	EXT1	SOU EXTENSION 1 FILED	—
Oct 12, 1999	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 20, 1999	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 18, 1999	NPUB	NOTICE OF PUBLICATION	—
May 27, 1999	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Apr 12, 1999	DOCK	ASSIGNED TO EXAMINER	—

MOLECULAR ANGIOPLASTY